SCHEMBL7487101

SCHEMBL7487101

Clc1nnc(N2CCNCC2)c2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
GFER P55789 1/20 0.70
HPGD P15428 1/20 0.52
HTR2C P28335 2/20 0.51
MAPT P10636 2/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ADRB1 P08588 1/20 0.49
HTR6 P50406 2/20 0.47
TSHR P16473 2/20 0.46
PKM P14618 1/20 0.46
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30170649 0.84 KMT2A (0.50) MEN1KMT2AGFERHTR2CKDM4E
SCHEMBL2210096 0.82 MEN1 (1.00) MEN1KMT2AGFERHPGDMAPT
SCHEMBL27829670 0.81 KMT2A (0.72) MEN1KMT2AGFERHPGDMAPT
SCHEMBL12786172 0.79 KMT2A (0.70) MEN1KMT2AGFERHPGDMAPT
SCHEMBL31678612 0.79 KDM4E (0.52) MEN1KMT2AHPGDHTR2CMAPT
SCHEMBL1396118 0.79 KMT2A (0.70) MEN1KMT2AGFERHPGDTSHR
SCHEMBL1102295 0.79 MEN1 (0.55) MEN1KMT2AGFERHPGDTSHR
SCHEMBL3669381 0.79 MEN1 (0.55) MEN1KMT2AGFERHPGDTSHR
SCHEMBL21221773 0.79 KMT2A (0.71) MEN1KMT2AMAPTHSD17B10PKM
SCHEMBL1091847 0.77 KMT2A (0.54) MEN1KMT2AGFERHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346622-B1 ENANTIOMORPHS AND ISOMERS ABBOTT LABORATORIES 2002-02-12 US disclosed
EP-1025100-B1 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES, METHOD FOR PRODUCING THE SAME, AND THEIR USE BASF AG (DE) 2002-01-23 EP disclosed
EP-1140099-A1 UTILISATION OF 2-SUBSTITUTED 1,2-BENZISOTHIAZOLE DERIVATIVES AND 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES FOR THE PROPHYLAXIS AND THERAPY OF CEREBRAL ISCHAEMIA BASF AKTIENGESELLSCHAFT (DE) 2001-10-10 EP disclosed
EP-1034170-A1 2-SUBSTITUTED 1,2-BENZISOTHIAZOLE DERIVATIVES AND THEIR USE AS SEROTONIN ANTAGONISTS (5-HT1A, 5-HT1B AND 5-HT1D) BASF AKTIENGESELLSCHAFT (DE) 2000-09-13 EP disclosed
WO-2000041697-A1 UTILISATION OF 2-SUBSTITUTED 1,2-BENZISOTHIAZOLE DERIVATIVES AND 3-SUBSTITUTED TETRAHYDROPYRIDOPYRIMIDINONE DERIVATIVES FOR THE PROPHYLAXIS AND THERAPY OF CEREBRAL ISCHAEMIA BASF AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed
WO-1999020616-A1 2-SUBSTITUTED 1,2-BENZISOTHIAZOLE DERIVATIVES AND THEIR USE AS SEROTONIN ANTAGONISTS (5-HT1A, 5-HT1B AND 5-HT1D) BASF AKTIENGESELLSCHAFT (DE) 1999-04-29 WO disclosed